Vantage Investment Advisors, LLC - CONTRAVIR PHARMACEUTICALS IN ownership

CONTRAVIR PHARMACEUTICALS IN's ticker is CTRVXXXX and the CUSIP is 21234W103. A total of 33 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Vantage Investment Advisors, LLC ownership history of CONTRAVIR PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2018$0143
-87.6%
0.00%
Q1 2018$01,1500.0%0.00%
Q4 2017$0
-100.0%
1,1500.0%0.00%
Q3 2017$1,0000.0%1,1500.0%0.00%
Q2 2017$1,000
-50.0%
1,1500.0%0.00%
-100.0%
Q1 2017$2,000
+100.0%
1,1500.0%0.00%
Q4 2016$1,0000.0%1,1500.0%0.00%
Q3 2016$1,0000.0%1,1500.0%0.00%
Q2 2016$1,0000.0%1,1500.0%0.00%
Q1 2016$1,000
-50.0%
1,1500.0%0.00%
-100.0%
Q4 2015$2,0000.0%1,150
+15.0%
0.00%0.0%
Q3 2015$2,000
-60.0%
1,0000.0%0.00%
-66.7%
Q2 2015$5,000
+66.7%
1,0000.0%0.00%
+200.0%
Q1 2015$3,0001,0000.00%
Other shareholders

There were no reported owners of CONTRAVIR PHARMACEUTICALS IN in Q4 2015.

NameSharesValueWeighting ↓
View complete list of CONTRAVIR PHARMACEUTICALS IN shareholders